Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janine Reichenbach

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Blood|May 25, 2010
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous diseaseFelix Meissner, Reinhard A Seger, Despina Moshous, et al.
Neuroimmunomodulation|February 28, 2015
Preliminary Evidence for a Compromised T-Cell Compartment in Maltreated Children with Depression and Posttraumatic Stress DisorderHannes Bielas, Andreas Jud, Ulrich Lips, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Defective nuclear entry of hydrolases prevents neutrophil extracellular trap formation in patients with chronic granulomatous diseaseSusana Romao, Emilio Tejera, Katarzyna J Nytko, et al.
European Journal of Pediatrics|February 8, 2006
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndromeNicola Strnad-Trojan, Richard Linde, Janine Reichenbach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 4, 2010
Gene therapy of chronic granulomatous disease: the engraftment dilemmaManuel Grez, Janine Reichenbach, Joachim Schwäble, et al.
Blood|June 23, 2009
Restoration of NET formation by gene therapy in CGD controls aspergillosisMatteo Bianchi, Abdul Hakkim, Volker Brinkmann, et al.
Current Gene Therapy|September 24, 2014
Gene therapy for chronic granulomatous disease: current status and future perspectivesKerstin B Kaufmann, Maria Chiriaco, Ulrich Siler, et al.
Scientific Reports|November 8, 2023
Expression of a large coding sequence: Gene therapy vectors for Ataxia TelangiectasiaTanja Hirch, Nadine Brander, Franziska Schenk, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
From idiopathic infectious diseases to novel primary immunodeficienciesJean-Laurent Casanova, Claire Fieschi, Jacinta Bustamante, et al.
Cerebellum (London, England)|November 10, 2009
Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced ageMatthias Kieslich, Franziska Hoche, Janine Reichenbach, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Blood|May 25, 2010
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous diseaseFelix Meissner, Reinhard A Seger, Despina Moshous, et al.
Neuroimmunomodulation|February 28, 2015
Preliminary Evidence for a Compromised T-Cell Compartment in Maltreated Children with Depression and Posttraumatic Stress DisorderHannes Bielas, Andreas Jud, Ulrich Lips, et al.
The Journal of Allergy and Clinical Immunology|November 2, 2015
Defective nuclear entry of hydrolases prevents neutrophil extracellular trap formation in patients with chronic granulomatous diseaseSusana Romao, Emilio Tejera, Katarzyna J Nytko, et al.
European Journal of Pediatrics|February 8, 2006
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndromeNicola Strnad-Trojan, Richard Linde, Janine Reichenbach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 4, 2010
Gene therapy of chronic granulomatous disease: the engraftment dilemmaManuel Grez, Janine Reichenbach, Joachim Schwäble, et al.
Blood|June 23, 2009
Restoration of NET formation by gene therapy in CGD controls aspergillosisMatteo Bianchi, Abdul Hakkim, Volker Brinkmann, et al.
Current Gene Therapy|September 24, 2014
Gene therapy for chronic granulomatous disease: current status and future perspectivesKerstin B Kaufmann, Maria Chiriaco, Ulrich Siler, et al.
Scientific Reports|November 8, 2023
Expression of a large coding sequence: Gene therapy vectors for Ataxia TelangiectasiaTanja Hirch, Nadine Brander, Franziska Schenk, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
From idiopathic infectious diseases to novel primary immunodeficienciesJean-Laurent Casanova, Claire Fieschi, Jacinta Bustamante, et al.
Cerebellum (London, England)|November 10, 2009
Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced ageMatthias Kieslich, Franziska Hoche, Janine Reichenbach, et al.
Pageof 7